CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 29.045

Change

-0.33 (-1.12)%

Market Cap

USD 0.28B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.44 (-0.85%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.14 (-0.85%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.83%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.23 (-0.80%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.34 (-1.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.28 (-0.89%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

-0.34 (-0.73%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.44 (-0.86%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.60 (-0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.11 (-0.48%)

USD 79.79B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.75% 98% N/A 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.75% 98% N/A 96% N/A
Trailing 12 Months  
Capital Gain 45.59% 95% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.59% 95% A 93% A
Trailing 5 Years  
Capital Gain 48.96% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.96% 68% D+ 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 1.86% 38% F 38% F
Dividend Return 2.10% 39% F 38% F
Total Return 0.24% 23% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 17.62% 25% F 38% F
Risk Adjusted Return 11.94% 30% F 32% F
Market Capitalization 0.28B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.